Author: ParadigMS Foundation
Our goal is to improve patient care for MS, NMOSD, and MOGAD by providing expertly curated learning materials and advanced, clinically relevant CME. By participating in our survey, you help us create high-quality CME content tailored for neurologists and residents.(function(t,e,s,n){var o,a,c;t.SMCX=t.SMCX||[],e.getElementById(n)||(o=e.getElementsByTagName(s),a=o[o.length-1],c=e.createElement(s),c.type="text/javascript",c.async=!0,c.id=n,c.src="https://widget.surveymonkey.com/collect/website/js/tRaiETqnLgj758hTBazgd30kMLlLtc4okiu60NJiBPZu9Pu7frGyKPjuqrS_2BHQan.js",a.parentNode.insertBefore(c,a))})(window,document,"script","smcx-sdk");...
REGISTER NOW! Live webinar on the use of generic, biosimilar and non-biologic complex drugs for multiple sclerosis
deutschLive webinar on the use of generic, biosimilar and non-biologic complex drugs for multiple sclerosis – Second edition – with German translation!Join this webinar and familiarise yourself with the robust European regulatory processes and effective oversight for generic, biosimilar, and follow-on non-biologic complex drugs (NBCDs) of disease modifying therapies in multiple sclerosis.This webinar will allow you to have informed conversations with your patients about the potential use of these agents.Register nowFind out more information on the event site here: Webinar info Live-Webinar über...
ParadigMS at EAN Congress 2024
The 10th Congress of the European Academy of Neurology (EAN) took place in Helsinki, Finland (and online) from 29 June to 2 July 2024. ParadigMS joined this event, engaging with Neurohood visitors to discuss our unique learning initiatives and efforts to foster awareness within the neurology community.As ParadigMS, we support the European Academy of Neurology’s efforts to advocate for Brain Health. Brain Health is about prevention, protection, and policy interventions. A crucial element of the Brain Health strategy focuses on boosting and empowering the workforce of health professionals within...
Newsletter – ParadigMS Foundation for Summer 2024!
Over the past six months, our Members dedicated their expertise to publish an article on the hot topic of multiple sclerosis in individuals aged 55 and above. It was a fruitful collaboration with the European Charcot Foundation.On top of this, our Belgian colleagues discussed the important topic of differential diagnosis in MS, NMO-SD and MOGAD.With our Board we decided to work on the topic of generics, biosimilars and NBCDs for multiple sclerosis.We were also pleased to be invited to speak about AI and prognostication, smouldering disease, stem cell transplantation...
Live webinar on the use of generics, biosimilars and NBCDs for Multiple Sclerosis
On June 11th 2024, FROM 3:30 TO 4:30 PM we had the pleasure of running a highly insightful live webinar on the use of generics, biosimilars, and NBCDs for Multiple Sclerosis, led by two outstanding experts, Professor Celia Oreja-Guevara and Professor Thomas Bergen.Who attended: Neurologists, opthamologists, radiologists and other HCP as well as industry representatives from more than 30 countries.Key Takeaways:In Europe, there are robust regulatory processes specific for generics, biosimilars and follow-on NBCDs to ensure that in Europe these agents can be considered equally effective and safe...